A recent study has shown that melatonin, a compound found in the lungs, acts as a barrier against the Corona virus, by blocking the genes that encode proteins in the cells in the nose and lung alveoli, and the epithelial cells lining the alveoli, which are the entry points for the virus.
The discovery made by researchers at the University of São Paulo (USPIn Brazil, in understanding why some people are not infected or not showing symptoms of Corona, even when they have been reliably diagnosed with the virus by testing PCR.
In addition, it offers the possibility of administering the hormone melatonin through the nose, in the form of drops or spray, to prevent the disease from developing in patients with pre-symptomatic patients.
Melation–
The researchers confirmed in an article about the study published in the journal Melatonin Research Preclinical and clinical trials will be needed to demonstrate the therapeutic efficacy of melatonin against the virus.
According to the researchers, melatonin produced in the lung has been shown to act as a barrier that prevents the virus from entering cells, stimulates the immune system and stimulates the production of antibodies.
And because melatonin in the lung prevents transcription of these genes that encode proteins into the cells of the entry point of the virus, using melatonin directly in the lungs in the form of drops or spray can prevent the virus.
The researchers note that more research is needed to prove that this is indeed the case, and according to the researchers, another idea could be by using the pulmonary melatonin scale index, as a predictive biological indicator to detect corona symptom vectors.
– .
